31. Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers. Issue 7 (27th July 2022) Authors: Nebot-Bral, Laetitia; Hollebecque, Antoine; Yurchenko, Andrey A; de Forceville, Louise; Danjou, Mathieu; Jouniaux, Jean-Mehdi; Rosa, Reginaldo C A; Pouvelle, Caroline; Aoufouchi, Said; Vuagnat, Perrine; Smolenschi, Cristina; Colomba, Emeline; Leary, Alexandra; Marabelle, Aurelien; Scoazec, Jean-Y... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 7(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells. (7th November 2013) Authors: Valsesia-Wittmann, Sandrine; Clemenceau, Beatrice; Jallas, Anne-Catherine; Blay, Jean-Yves; Marabelle, Aurelien; Caux, Christophe; Vie, Henri Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study. (May 2022) Authors: Marabelle, Aurelien; Cassier, Philippe A; Fakih, Marwan; Kao, Steven; Nielsen, Dorte; Italiano, Antoine; Guren, Tormod Kyrre; van Dongen, Marloes G J; Spencer, Kristen; Bariani, Giovanni Mendonca; Ascierto, Paolo A; Santoro, Armando; Shah, Manisha; Asselah, Jamil; Iqbal, Syma; Takahashi, Shunji; ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 5(2022) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study. Issue 7 (1st March 2022) Authors: O'Malley, David M.; Bariani, Giovanni Mendonca; Cassier, Philippe A.; Marabelle, Aurelien; Hansen, Aaron R.; De Jesus Acosta, Ana; Miller, Wilson H.; Safra, Tamar; Italiano, Antoine; Mileshkin, Linda; Xu, Lei; Jin, Fan; Norwood, Kevin; Maio, Michele Journal: Journal of clinical oncology Issue: Volume 40:Issue 7(2022) Page Start: 752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma. (March 2022) Authors: Sonpavde, Guru P.; Sternberg, Cora N.; Loriot, Yohann; Marabelle, Aurelien; Lee, Jae Lyun; Fléchon, Aude; Roubaud, Guilhem; Pouessel, Damien; Zagonel, Vittorina; Calabro, Fabio; Banna, Giuseppe L.; Shin, Sang Joon; Vera-Badillo, Francisco E.; Powles, Thomas; Hellmis, Eva; Miranda, Paulo A.P.; Lim... Journal: European journal of cancer Issue: Volume 163(2022) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. Repurposing infectious disease vaccines for intratumoral immunotherapy. Issue 1 (25th February 2020) Authors: Melero, Ignacio; Gato, Maria; Shekarian, Tala; Aznar, Angela; Valsesia-Wittmann, Sandrine; Caux, Christophe; Etxeberrria, Iñaki; Teijeira, Alvaro; Marabelle, Aurelien Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. Sequential tumor and dual immune targeted immunotherapy: anti-lymphoma activity of Rituximab with 4-1bb stimulation and PD-1 blockade. (6th November 2014) Authors: Mueller, Antonia MS; Hebb, Jonathan; Sagiv-Barfi, Idit; Marabelle, Aurelien; Houot, Roch; Rajapaksa, Amanda; Czerwinski, Debra K; Chang, Serena; Chester, Cariad; Sadaram, Mohith; Waller, Erin; Levy, Ronald; Kohrt, Holbrook Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma. Issue 8 (5th August 2022) Authors: Costa, Ana; Thirant, Cécile; Kramdi, Amira; Pierre-Eugène, Cécile; Louis-Brennetot, Caroline; Blanchard, Orphée; Surdez, Didier; Gruel, Nadege; Lapouble, Eve; Pierron, Gaëlle; Sitbon, Deborah; Brisse, Hervé; Gauthier, Arnaud; Fréneaux, Paul; Bohec, Mylène; Raynal, Virginie; Baulande, Sylvain; Lec... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis. (3rd May 2016) Authors: Vences-Catalán, Felipe; Rajapaksa, Ranjani; Srivastava, Minu K.; Marabelle, Aurelien; Kuo, Chiung-Chi; Levy, Ronald; Levy, Shoshana Journal: Oncoimmunology Issue: Volume 5:Number 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Tumour mutational burden in treatment-resistant tumours – Authors' reply. Issue 12 (December 2020) Authors: Marabelle, Aurelien; Jin, Fan; Norwood, Kevin; Aurora-Garg, Deepti Journal: Lancet oncology Issue: Volume 21:Issue 12(2020) Page Start: e552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗